CY2018002I1 - Εγκαρσια συνδεδεμενα πολυμερη εναλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας - Google Patents

Εγκαρσια συνδεδεμενα πολυμερη εναλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας

Info

Publication number: CY2018002I1
Authority: CY; Cyprus
Prior art keywords: hyperkalasemia; compositions; treatment; cross; cation exchange
Prior art date: 2008-08-22

Application number

CY2018002C

Other languages

English (en)

Original Assignee

Vifor (International) Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-22

Filing date

2018-01-15

Publication date

2019-07-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41707686&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2018002(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-01-15 Application filed by Vifor (International) Ltd. filed Critical Vifor (International) Ltd.

2019-07-10 Publication of CY2018002I1 publication Critical patent/CY2018002I1/el

Links

238000005341 cation exchange Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229920000642 polymer Polymers 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/16—Organic material
- B01J39/18—Macromolecular compounds
- B01J39/20—Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/22—Esters containing halogen
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/34—Monomers containing two or more unsaturated aliphatic radicals
- C08F212/36—Divinylbenzene

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Polymers & Plastics (AREA)
Hematology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Processes Of Treating Macromolecular Substances (AREA)

CY2018002C 2008-08-22 2018-01-15 Εγκαρσια συνδεδεμενα πολυμερη εναλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας CY2018002I1 (el)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US9109708P	2008-08-22	2008-08-22
US9111008P	2008-08-22	2008-08-22
US9112508P	2008-08-22	2008-08-22
US16589409P	2009-04-01	2009-04-01
US16589909P	2009-04-01	2009-04-01
US16590509P	2009-04-02	2009-04-02
PCT/US2009/054706 WO2010022383A2 (en)	2008-08-22	2009-08-22	Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia

Publications (1)

Publication Number	Publication Date
CY2018002I1 true CY2018002I1 (el)	2019-07-10

Family

ID=41707686

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CY2018002C CY2018002I1 (el)	2008-08-22	2018-01-15	Εγκαρσια συνδεδεμενα πολυμερη εναλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας
CY20181101268T CY1120930T1 (el)	2008-08-22	2018-11-29	Εγκαρσια συνδεδεμενα πολυμερη ανταλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας
CY2019002C CY2019002I2 (el)	2008-08-22	2019-01-09	Εγκαρσια συνδεδεμενα πολυμερη ανταλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CY20181101268T CY1120930T1 (el)	2008-08-22	2018-11-29	Εγκαρσια συνδεδεμενα πολυμερη ανταλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας
CY2019002C CY2019002I2 (el)	2008-08-22	2019-01-09	Εγκαρσια συνδεδεμενα πολυμερη ανταλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας

Country Status (27)

Country	Link
US (4)	US20110236340A1 (el)
EP (4)	EP3431094B1 (el)
JP (7)	JP5756403B2 (el)
KR (5)	KR102150184B1 (el)
CN (2)	CN103919792B (el)
AU (1)	AU2009282721B2 (el)
BR (1)	BRPI0917853C1 (el)
CA (1)	CA2735058C (el)
CY (3)	CY2018002I1 (el)
DE (1)	DE112009002063T5 (el)
DK (3)	DK2365988T4 (el)
ES (3)	ES2545887T5 (el)
FI (1)	FI3431094T3 (el)
GB (4)	GB2475657B (el)
HK (1)	HK1184675A1 (el)
HR (3)	HRP20230091T1 (el)
HU (3)	HUE061320T2 (el)
LT (4)	LT2957286T (el)
LU (1)	LUC00094I2 (el)
MX (2)	MX364398B (el)
NL (1)	NL300962I2 (el)
NO (2)	NO2018004I1 (el)
PL (3)	PL2365988T5 (el)
PT (3)	PT3431094T (el)
SI (2)	SI3431094T1 (el)
SM (1)	SMT201500207T1 (el)
WO (1)	WO2010022383A2 (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8574716B2 (en) *	2006-01-23	2013-11-05	Hitachi Chemical Co., Ltd.	Ionic polymer devices and methods of fabricating the same
WO2010022380A2 (en)	2008-08-22	2010-02-25	Relypsa, Inc.	Linear polyol stabilized polyfluoroacrylate compositions
ES2545887T5 (es)	2008-08-22	2020-02-17	Vifor Int Ltd	Polímeros reticulados de intercambio catiónico, composiciones y uso en el tratamiento de la hiperpotasemia
ES2670580T3 (es) *	2010-03-20	2018-05-31	Relypsa, Inc.	Procedimiento continuo para preparar partículas de polifluoroacrilato
EP2673237B1 (en)	2011-02-11	2018-11-07	ZS Pharma, Inc	Use of a zirconium silicate for the treatment of hyperkalemia
CN110028603A (zh)	2011-06-27	2019-07-19	瑞立普萨公司	用于将聚合酯转化为聚合酸的方法
ES2758708T3 (es)	2011-06-27	2020-05-06	Relypsa Inc	Fluoración de ésteres de acrilato y derivados
CA2879425A1 (en) *	2012-07-19	2014-01-23	Relypsa, Inc.	Compositions comprising crosslinked cation-binding polymers
US9982940B2 (en)	2012-08-09	2018-05-29	Patheon Austria Gmbh & Co Kg	Process for drying polymeric materials
EP2916851A2 (en) *	2012-10-08	2015-09-16	Relypsa, Inc.	Potassium-binding agents for treating hypertension and hyperkalemia
US10695365B2 (en)	2012-10-22	2020-06-30	ZS Pharma, Inc.	Microporous zirconium silicate for the treatment of hyperkalemia
JP6280636B2 (ja)	2013-04-05	2018-02-14	ズィーエス・ファーマ，インコーポレーテッド	カリウムの低減と慢性腎臓病及び／または慢性心臓病の治療のための微多孔性ケイ酸ジルコニウム及び利尿剤
MX2017007603A (es) *	2014-12-23	2017-10-19	Ardelyx Inc	Composiciones y metodos para tratar hiperpotasemia.
WO2017040520A1 (en)	2015-08-31	2017-03-09	Hitachi Chemical Co., Ltd.	Molecular methods for assessing urothelial disease
US9592253B1 (en)	2015-10-14	2017-03-14	ZS Pharma, Inc.	Extended use zirconium silicate compositions and methods of use thereof
ITUB20159278A1 (it)	2015-12-23	2017-06-23	Rjw Pharma Llc	Procedimento per la sintesi di patiromer
WO2019220450A1 (en)	2018-05-16	2019-11-21	Solara Active Pharma Sciences Limited	Process for preparation of patiromer
MX2021011044A (es) *	2019-03-13	2021-10-13	Astrazeneca Ab	Agentes de union a potasio para su uso en pacientes de hemodialisis.
CN114867710A (zh) *	2019-11-14	2022-08-05	维福(国际)有限公司	2-氟代丙烯酸烷基酯的一步合成
CN116323717A (zh) *	2021-09-13	2023-06-23	中美华世通生物医药科技(武汉)股份有限公司	治疗高钾血症的聚合物药物及其制备方法
US20240139234A1 (en) *	2021-11-17	2024-05-02	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Pharmaceutical polymer for treating hyperkalemia and preparation method thereof
CN114369729B (zh) *	2021-12-28	2023-11-03	江苏容汇通用锂业股份有限公司	一种利用锂矿渣进行浸出液除钾的工艺
CN114394918B (zh) *	2022-01-19	2023-10-20	罗长青	一种2-[[三(羟甲基)甲基]氨基]乙磺酸的制备方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2611730A (en) *	1950-09-02	1952-09-23	Simth Kline & French Lab	Medical preparation for reducing the body level of sodium
US2909462A (en) *	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
US3499960A (en) *	1965-01-25	1970-03-10	Merck & Co Inc	Palatable coated particles of an anion exchange resin
NL137053C (el) †	1967-01-30
FR2171934B1 (el) *	1972-02-16	1974-09-13	Rhone Poulenc Sa
US3974272A (en) *	1972-09-01	1976-08-10	Merck & Co., Inc.	Palatable cholestyramine coacervate compositions
US4143130A (en) *	1977-08-29	1979-03-06	Warren-Teed Laboratories, Inc.	Method for treating kidney stones
US4470975A (en) *	1977-10-21	1984-09-11	The Johns Hopkins University	Method and composition for the elimination of water from an animal body
US4380590A (en) *	1978-09-19	1983-04-19	Rohm And Haas Company	Emulsion copolymer cation exchange resins
DE2846187A1 (de) †	1978-10-24	1980-05-08	Bayer Ag	Kunstharze auf basis vernetzter mischpolymerisate aus mono- und polyvinylverbindungen
JPS6090243A (ja) *	1983-10-25	1985-05-21	Nitto Boseki Co Ltd	小球状モノアリルアミン橋かけ重合体の製造方法
US4747881A (en) *	1985-02-05	1988-05-31	Warner-Lambert Company	Ingestible aggregate and delivery system prepared therefrom
US5186937A (en) *	1985-06-07	1993-02-16	A.E.C. Societe De Chimie Organique Et Biologique	Composition for feeding ruminants
IT1190349B (it) *	1986-06-16	1988-02-16	Prodotti Formenti Srl	Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
JPS63218713A (ja) *	1987-02-17	1988-09-12	Daikin Ind Ltd	α−フルオロアクリル酸系重合体ならびに用途
US4837015A (en) *	1987-03-05	1989-06-06	Carolina Medical Products Company, Inc.	Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels
GB8817015D0 (en) *	1988-07-16	1988-08-17	Reckitt & Colmann Prod Ltd	Method of treatment
GB8829088D0 (en) †	1988-12-13	1989-01-25	Smith Kline French Lab	Compounds
US5236701A (en) *	1989-07-19	1993-08-17	Lowchol Scientific Inc.	Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
DE3928990A1 (de)	1989-09-01	1991-03-07	Bayer Ag	Verfahren zur herstellung von (alpha)-fluoroacrylsaeurederivaten
US5112993A (en)	1989-11-14	1992-05-12	E. I. Du Pont De Nemours And Company	Process for the preparation of difluoromaleic anhydride
US5091175A (en) *	1990-05-14	1992-02-25	Erbamont Inc.	Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
EP0464299B1 (en) *	1990-07-04	1995-01-11	Marcin Krotkiewski	Antihypertensive preparation
US5162110A (en) *	1990-12-19	1992-11-10	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Binding theophylline to ion exchange resins
US5281631A (en) *	1991-12-20	1994-01-25	Arch Development Corp.	Phosphonic acid based ion exchange resins
DE69306844T2 (de) †	1992-04-10	1997-07-10	Mitsubishi Chem Corp	Verfahren zur Herstellung von kugelförmigen vernetzten Acrylnitril-Copolymerisaten
NZ255758A (en) *	1992-08-20	1997-10-24	Du Pont	Crosslinked polymeric ammonium salts useful as bile sequestrants
US5487888A (en) *	1993-05-20	1996-01-30	Geltex, Inc.	Iron-binding polymers for oral administration
US5618530A (en) *	1994-06-10	1997-04-08	Geltex Pharmaceuticals, Inc.	Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5607669A (en) *	1994-06-10	1997-03-04	Geltex Pharmaceuticals, Inc.	Amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) *	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US5718920A (en) *	1993-11-25	1998-02-17	Salternate B.V.	Particles for binding monovalent cations
TW474813B (en) *	1994-06-10	2002-02-01	Geltex Pharma Inc	Alkylated composition for removing bile salts from a patient
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
US5824339A (en) *	1995-09-08	1998-10-20	Takeda Chemical Industries, Ltd	Effervescent composition and its production
US6623759B2 (en) *	1996-06-28	2003-09-23	Astrazeneca Ab	Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US5935599A (en) *	1996-10-28	1999-08-10	The Board Of Trustees Of The University Of Illinois	Polymer-associated liposomes for drug delivery and method of manufacturing the same
US6280717B1 (en) *	1998-07-31	2001-08-28	Nikken Chemicals Co., Ltd.	Cation exchange resin preparation
US6294163B1 (en) *	1998-10-02	2001-09-25	Geltex Pharmaceuticals, Inc.	Polymers containing guanidinium groups as bile acid sequestrants
US6558665B1 (en) *	1999-05-18	2003-05-06	Arch Development Corporation	Encapsulating particles with coatings that conform to size and shape of the particles
US6733780B1 (en) *	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
US20020054903A1 (en) *	1999-10-19	2002-05-09	Joseph Tyler	Direct compression polymer tablet core
DE19951116A1 (de)	1999-10-23	2001-04-26	Bosch Gmbh Robert	Relais, insbesondere für eine Startvorrichtung
DE19962935A1 (de) †	1999-12-24	2001-06-28	Bayer Ag	Verfahren zur Herstellung von vernetzten Ionenaustauschern auf Basis von ungesättigten, aliphatischen Nitrilen
WO2001051063A1 (fr) *	2000-01-14	2001-07-19	Otsuka Pharmaceutical Factory, Inc.	Inhibiteurs de l'absorption de l'ion sodium, et agents prophylactiques ou therapeutiques et produits alimentaires renfermant lesdits inhibiteurs
US6994827B2 (en)	2000-06-03	2006-02-07	Symyx Technologies, Inc.	Parallel semicontinuous or continuous reactors
ATE407689T1 (de) *	2000-08-01	2008-09-15	Oryza Oil & Fat Chem	Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess
WO2002040039A2 (en) *	2000-11-20	2002-05-23	Dow Global Technologies Inc.	In vivo use of water absorbent polymers
US7033639B2 (en) *	2001-05-16	2006-04-25	Rohm And Haas Company	Polyaniline coating composition
US6881484B2 (en) *	2001-05-30	2005-04-19	Mitsubishi Kagaku Iatron, Inc.	Core-shell particle including signal-generating substance enclosed therein and process for producing the same
DK2316551T3 (da) *	2003-02-25	2013-01-02	Dupont Nutrition Biosci Aps	Simulated Moving Bed- (SMB) system
US7381428B2 (en)	2003-08-26	2008-06-03	Shire International Licensing B.V.	Stabilized lanthanum carbonate compositions
US7429394B2 (en) *	2004-03-30	2008-09-30	Relypsa, Inc.	Ion binding compositions
US7854924B2 (en) *	2004-03-30	2010-12-21	Relypsa, Inc.	Methods and compositions for treatment of ion imbalances
US8282960B2 (en) *	2004-03-30	2012-10-09	Relypsa, Inc.	Ion binding compositions
JP4964122B2 (ja) *	2004-03-30	2012-06-27	レリプサ，インコーポレイテッド	イオン結合組成物
US7556799B2 (en) *	2004-03-30	2009-07-07	Relypsa, Inc.	Ion binding polymers and uses thereof
US8192758B2 (en) *	2004-03-30	2012-06-05	Relypsa, Inc.	Ion binding compositions
WO2007038801A2 (en) †	2005-09-30	2007-04-05	Ilypsa, Inc.	Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
DE112006002617T5 (de) *	2005-09-30	2008-08-28	Ilypsa Inc., Santa Clara	Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite
JP2009510126A (ja) *	2005-09-30	2009-03-12	レリプサ，インコーポレイテッド	哺乳類の胃腸管からカリウムイオンを選択的に除去するための方法および組成物
MX2010002256A (es) *	2007-08-29	2010-06-23	Sorbent Therapeutics Inc	Composiciones polimericas absorbentes con contenido variable de contraiones y sus metodos de preparacion y uso.
US20100111892A1 (en) *	2008-08-22	2010-05-06	Relypsa, Inc.	Crosslinked polyfluoroacrylic acid and processes for the preparation thereof
WO2010022380A2 (en) *	2008-08-22	2010-02-25	Relypsa, Inc.	Linear polyol stabilized polyfluoroacrylate compositions
ES2545887T5 (es) †	2008-08-22	2020-02-17	Vifor Int Ltd	Polímeros reticulados de intercambio catiónico, composiciones y uso en el tratamiento de la hiperpotasemia
US20100104527A1 (en) *	2008-08-22	2010-04-29	Relypsa, Inc.	Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties

2009
- 2009-08-22 ES ES09748557T patent/ES2545887T5/es active Active
- 2009-08-22 JP JP2011524060A patent/JP5756403B2/ja active Active
- 2009-08-22 ES ES18188764T patent/ES2939021T3/es active Active
- 2009-08-22 PL PL09748557T patent/PL2365988T5/pl unknown
- 2009-08-22 ES ES15171701T patent/ES2699494T3/es active Active
- 2009-08-22 EP EP18188764.7A patent/EP3431094B1/en active Active
- 2009-08-22 DK DK09748557.7T patent/DK2365988T4/da active
- 2009-08-22 DK DK15171701.4T patent/DK2957286T3/en active
- 2009-08-22 GB GB1104561.4A patent/GB2475657B/en active Active
- 2009-08-22 HR HRP20230091TT patent/HRP20230091T1/hr unknown
- 2009-08-22 EP EP15171701.4A patent/EP2957286B1/en active Active
- 2009-08-22 PT PT181887647T patent/PT3431094T/pt unknown
- 2009-08-22 MX MX2015000657A patent/MX364398B/es unknown
- 2009-08-22 KR KR1020187035573A patent/KR102150184B1/ko active IP Right Grant
- 2009-08-22 SI SI200932178T patent/SI3431094T1/sl unknown
- 2009-08-22 KR KR1020207032030A patent/KR102300471B1/ko active IP Right Grant
- 2009-08-22 CN CN201410106433.5A patent/CN103919792B/zh active Active
- 2009-08-22 KR KR1020187002772A patent/KR101928973B1/ko active IP Right Grant
- 2009-08-22 CN CN200980137593.3A patent/CN102202670B/zh active Active
- 2009-08-22 KR KR1020117006635A patent/KR101825113B1/ko active IP Right Grant
- 2009-08-22 EP EP09748557.7A patent/EP2365988B2/en active Active
- 2009-08-22 FI FIEP18188764.7T patent/FI3431094T3/fi active
- 2009-08-22 PL PL15171701T patent/PL2957286T3/pl unknown
- 2009-08-22 SI SI200931889T patent/SI2957286T1/sl unknown
- 2009-08-22 DE DE112009002063T patent/DE112009002063T5/de not_active Ceased
- 2009-08-22 LT LTEP15171701.4T patent/LT2957286T/lt unknown
- 2009-08-22 LT LTEP18188764.7T patent/LT3431094T/lt unknown
- 2009-08-22 DK DK18188764.7T patent/DK3431094T3/da active
- 2009-08-22 HU HUE18188764A patent/HUE061320T2/hu unknown
- 2009-08-22 US US13/060,207 patent/US20110236340A1/en not_active Abandoned
- 2009-08-22 AU AU2009282721A patent/AU2009282721B2/en active Active
- 2009-08-22 PT PT15171701T patent/PT2957286T/pt unknown
- 2009-08-22 EP EP22211737.6A patent/EP4201408A1/en active Pending
- 2009-08-22 WO PCT/US2009/054706 patent/WO2010022383A2/en active Application Filing
- 2009-08-22 PL PL18188764.7T patent/PL3431094T3/pl unknown
- 2009-08-22 BR BRPI0917853A patent/BRPI0917853C1/pt active IP Right Grant
- 2009-08-22 HU HUE09748557A patent/HUE025934T2/en unknown
- 2009-08-22 GB GB1222750.0A patent/GB2495427B/en active Active
- 2009-08-22 CA CA2735058A patent/CA2735058C/en active Active
- 2009-08-22 MX MX2011001893A patent/MX2011001893A/es active IP Right Grant
- 2009-08-22 KR KR1020207006869A patent/KR102178208B1/ko active IP Right Grant
- 2009-08-22 PT PT97485577T patent/PT2365988E/pt unknown
2011
- 2011-11-22 HK HK13111423.9A patent/HK1184675A1/xx unknown
2012
- 2012-12-17 GB GB1222749.2A patent/GB2495426A/en not_active Withdrawn
- 2012-12-17 GB GB1222752.6A patent/GB2495428A/en not_active Withdrawn
2014
- 2014-05-12 JP JP2014098678A patent/JP2014144978A/ja not_active Withdrawn
- 2014-05-12 JP JP2014098677A patent/JP5883471B2/ja active Active
2015
- 2015-09-02 SM SM201500207T patent/SMT201500207T1/xx unknown
- 2015-09-09 HR HRP20150955TT patent/HRP20150955T1/hr unknown
2016
- 2016-05-12 JP JP2016095867A patent/JP6232468B2/ja active Active
2017
- 2017-02-27 US US15/443,664 patent/US20170165292A1/en not_active Abandoned
- 2017-09-21 JP JP2017181132A patent/JP6633583B2/ja active Active
2018
- 2018-01-15 CY CY2018002C patent/CY2018002I1/el unknown
- 2018-01-15 LT LTPA2018004C patent/LTPA2018004I1/lt unknown
- 2018-01-17 NO NO2018004C patent/NO2018004I1/no unknown
- 2018-11-22 HR HRP20181961TT patent/HRP20181961T1/hr unknown
- 2018-11-29 CY CY20181101268T patent/CY1120930T1/el unknown
- 2018-12-13 LT LTPA2018016 patent/LTC2957286I2/lt unknown
- 2018-12-13 LU LU00094C patent/LUC00094I2/fr unknown
- 2018-12-14 NL NL300962C patent/NL300962I2/nl unknown
- 2018-12-14 NO NO2018041C patent/NO2018041I1/no unknown
- 2018-12-21 JP JP2018238997A patent/JP6890116B2/ja active Active
2019
- 2019-01-09 CY CY2019002C patent/CY2019002I2/el unknown
- 2019-01-15 HU HUS1900003C patent/HUS1900003I1/hu unknown
- 2019-11-01 US US16/672,005 patent/US20200289550A1/en not_active Abandoned
2020
- 2020-07-10 JP JP2020119093A patent/JP2020172537A/ja not_active Withdrawn
2021
- 2021-05-18 US US17/323,627 patent/US20220000906A1/en active Pending

Also Published As

Publication number	Publication date
LTC2957286I2 (lt)	2019-11-25
NL300962I1 (nl)	2018-12-28
GB2475657B (en)	2013-05-29
LT3431094T (lt)	2023-02-27
CY1120930T1 (el)	2020-05-29
EP2957286A1 (en)	2015-12-23
LTPA2018004I1 (lt)	2018-02-12
US20110236340A1 (en)	2011-09-29
PT3431094T (pt)	2023-03-03
AU2009282721A1 (en)	2010-02-25
GB2495427A (en)	2013-04-10
JP2017218454A (ja)	2017-12-14
HUE025934T2 (en)	2016-05-30
ES2699494T3 (es)	2019-02-11
EP2365988B2 (en)	2019-07-03
BRPI0917853B1 (pt)	2020-04-07
PL3431094T3 (pl)	2023-04-24
WO2010022383A3 (en)	2010-09-23
CY2019002I1 (el)	2020-05-29
LTPA2018016I1 (lt)	2019-01-10
BRPI0917853C1 (pt)	2021-05-25
LUC00094I2 (el)	2020-01-23
JP6232468B2 (ja)	2017-11-15
KR20200128600A (ko)	2020-11-13
HK1184675A1 (en)	2014-01-30
DK2365988T4 (da)	2019-10-07
CA2735058A1 (en)	2010-02-25
MX2011001893A (es)	2011-09-27
WO2010022383A2 (en)	2010-02-25
FI3431094T3 (fi)	2023-03-20
AU2009282721B2 (en)	2015-10-29
EP3431094B1 (en)	2022-12-07
KR101928973B1 (ko)	2018-12-13
KR20180014845A (ko)	2018-02-09
CN102202670A (zh)	2011-09-28
CY2019002I2 (el)	2020-05-29
GB201104561D0 (en)	2011-05-04
NL300962I2 (nl)	2020-06-02
EP2365988B1 (en)	2015-07-22
GB2475657A (en)	2011-05-25
US20200289550A1 (en)	2020-09-17
JP2014144977A (ja)	2014-08-14
GB2495426A (en)	2013-04-10
JP5756403B2 (ja)	2015-07-29
DK3431094T3 (da)	2023-02-20
NO2018004I1 (no)	2018-01-17
JP2016145256A (ja)	2016-08-12
KR20180133561A (ko)	2018-12-14
GB2495427B (en)	2013-08-07
KR20110063647A (ko)	2011-06-13
KR102150184B1 (ko)	2020-08-31
SI2957286T1 (sl)	2018-12-31
SMT201500207T1 (it)	2015-10-30
CN103919792A (zh)	2014-07-16
PT2957286T (pt)	2018-11-30
HUS1900003I1 (hu)	2019-02-28
JP2014144978A (ja)	2014-08-14
LT2957286T (lt)	2018-12-10
KR102300471B1 (ko)	2021-09-30
EP3431094A1 (en)	2019-01-23
HRP20150955T1 (hr)	2015-10-09
US20170165292A1 (en)	2017-06-15
HRP20181961T1 (hr)	2019-02-08
JP6633583B2 (ja)	2020-01-22
JP2012500806A (ja)	2012-01-12
PL2365988T3 (pl)	2015-12-31
MX364398B (es)	2019-04-24
PL2365988T5 (pl)	2019-11-29
HUE061320T2 (hu)	2023-06-28
DK2365988T3 (en)	2015-10-26
KR101825113B1 (ko)	2018-02-02
GB201222749D0 (en)	2013-01-30
JP2019065030A (ja)	2019-04-25
GB2495428A (en)	2013-04-10
GB201222750D0 (en)	2013-01-30
ES2545887T3 (es)	2015-09-16
EP4201408A1 (en)	2023-06-28
PL2957286T3 (pl)	2019-03-29
BRPI0917853A2 (pt)	2015-11-24
CN102202670B (zh)	2014-04-30
DE112009002063T5 (de)	2012-01-12
US20220000906A1 (en)	2022-01-06
PT2365988E (pt)	2015-10-22
JP2020172537A (ja)	2020-10-22
GB201222752D0 (en)	2013-01-30
DK2957286T3 (en)	2018-12-17
CN103919792B (zh)	2018-03-09
JP5883471B2 (ja)	2016-03-15
NO2018041I1 (el)	2018-12-14
EP2957286B1 (en)	2018-11-21
JP6890116B2 (ja)	2021-06-18
EP2365988A2 (en)	2011-09-21
ES2545887T5 (es)	2020-02-17
SI3431094T1 (sl)	2023-04-28
CA2735058C (en)	2021-01-26
HRP20230091T1 (hr)	2023-03-17
ES2939021T3 (es)	2023-04-18
KR102178208B1 (ko)	2020-11-12
BRPI0917853B8 (pt)	2020-04-22
KR20200029614A (ko)	2020-03-18
LUC00094I1 (el)	2018-12-19

Publication	Publication Date	Title
CY2019002I2 (el)	2020-05-29	Εγκαρσια συνδεδεμενα πολυμερη ανταλλαγης κατιοντος, συνθεσεις και χρηση στη θεραπεια υπερκαλιαιμιας
LTC2340031I2 (lt)	2022-06-27	Gdf gaudyklės, skirtos naudoti anemijos gydymui
BRPI0913574A2 (pt)	2015-11-24	composição de tratamento de acne compreendendo nanoprata e usos
CO6791606A2 (es)	2013-11-14	Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas
BRPI0819361A2 (pt)	2014-10-07	Composição de tratamento de cabelos e agente de tratamento
BRPI0807908A2 (pt)	2014-06-17	Melhoramentos em composições medicinais.
BRPI0915299A2 (pt)	2016-02-16	poliamida, composição compreendendo tal poliamida e utilização das mesmas
BRPI0922233A2 (pt)	2018-05-29	compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0911612A2 (pt)	2015-12-15	composições e métodos para o tratamento da esclerose múltipla.
BRPI0809272A2 (pt)	2014-10-14	Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro
BRPI0809802A2 (pt)	2014-10-07	"composição granular para tratamento de água, tablete para tratamento de água, composição para tratamento de água e método de tratamento de água para recreação"
DK2004183T3 (da)	2013-09-23	Mazindol-kombination i behandlingen af opmærksomhedsunderskud/hyperaktivitet
BRPI0812932A2 (pt)	2014-12-09	Composições e métodos de tratar câncer
BRPI0908139A2 (pt)	2015-08-11	Agente de formação de espuma para uma composição de dentifrício, composição de centifrício, e, método para tratamento e/ou alívio de xerostomia
DK3156057T3 (da)	2024-01-29	Delmopinol-belagt dyretyggeartikel til anvendelse til forebyggelsen eller behandlingen af halitosis
BRPI0810762A2 (pt)	2014-10-21	Composição para tratamento da água
BRPI0821100A2 (pt)	2017-05-23	composições e métodos para o tratamento de câncer de bexiga
FR2921558B1 (fr)	2009-11-20	Composition antimicrobienne utilisable en cosmetique et en dermatologie.
HUS1800004I1 (hu)	2018-02-28	Térhálósított kationcserélõ polimerek, az ezeket tartalmazó készítmények és alkalmazásuk hiperkalémia kezelésére
BR112012025829A2 (pt)	2017-07-18	''composição de tratamento, composição líquido e utilização''
SI2365988T1 (sl)	2015-10-30	Zamreženi polimeri za kationsko izmenjavo, sestave in uporaba pri zdravljenju hiperkaliemije
TH0801001896A (th)	2015-06-12	การใช้ 4-ไซโคลโพรพิลเมธอกซิ-n-(3,5-ไดคลอโร-1-ออกซิโด-ไพริดิน-4-อิล)-5-(เมธอกซิ)ไพริดีน-2-คาร์บอกซามีด ในการรักษาการบาดเจ็บไขสันหลัง